Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 4/20 | 0.86 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.58 |
| ▸ | LSS | P48449 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL5724808 | 0.93 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrapentylammonium SCHEMBL11428806 | 0.93 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL2007037 | 0.93 | SLC22A1 (1.00) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL71525 | 0.93 | SLC22A1 (1.00) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL22384 | 0.93 | SLC22A1 (1.00) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| SCHEMBL17238751 | 0.90 | SLC22A1 (0.87) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| SCHEMBL11416444 | 0.90 | SLC22A1 (0.87) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL3343598 | 0.90 | SLC22A1 (0.80) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrahexylammonium SCHEMBL11424947 | 0.90 | SLC22A1 (0.87) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL104673 | 0.90 | SLC22A1 (0.80) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260098348-A1 | ELECTROCHEMICAL CO-PRODUCTION OF HALOGEN AND HYDROGEN FROM WASTE PLASTIC | UNIV MICHIGAN (US) | 2026-04-09 | — | — | US | claimed |
| WO-2025238661-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF OSIMERTINIB | BDR LIFESCIENCES PRIVATE LIMITED (IN) | 2025-11-20 | — | — | WO | claimed |
| US-12415179-B2 | Process for recovering and reusing depolymerization catalyst | 9449710 CANADA INC. (CA) | 2025-09-16 | — | — | US | claimed |
| US-20240382941-A1 | PROCESS FOR RECOVERING AND REUSING DEPOLYMERIZATION CATALYST | 9449710 CANADA INC. (CA) | 2024-11-21 | — | — | US | claimed |
| CN-111615506-B | Formation of terephthalic acid esters | 9449710加拿大公司 | 2023-09-05 | — | — | CN | claimed |
| EP-3959190-A1 | PROCESS FOR RECOVERING AND REUSING DEPOLYMERIZATION CATALYST | 9449710 Canada Inc. (CA) | 2022-03-02 | — | — | EP | claimed |
| US-20210309601-A1 | TEREPHTHALIC ACID ESTERS FORMATION | 9449710 CANADA INC. (CA) | 2021-10-07 | — | — | US | claimed |
| EP-3330311-B1 | STORAGE STABLE 1K-POLYURETHANE-PREPREGS AND MOULDED ARTICLE MADE FROM SAME ON THE BASIS OF A POLYURETHANE COMPOSITION | EVONIK OPERATIONS GMBH (DE) | 2021-05-05 | — | — | EP | claimed |
| EP-3792271-A1 | A PROCESS FOR THE PREPARATION OF BRIVUDINE | Aurobindo Pharma Limited (IN) | 2021-03-17 | — | — | EP | claimed |
| US-20200392067-A1 | TEREPHTHALIC ACID ESTERS FORMATION | 9449710 CANADA INC. (CA) | 2020-12-17 | — | — | US | claimed |
| US-20190084916-A1 | TEREPHTHALIC ACID ESTERS FORMATION | 9449710 CANADA INC. (CA) | 2019-03-21 | — | — | US | claimed |
| WO-2019016637-A1 | A PROCESS FOR THE PREPARATION OF DEFERASIROX | AUROBINDO PHARMA LIMITED (IN) | 2019-01-24 | — | — | WO | claimed |
| US-20180155515-A1 | STORAGE-STABLE ONE-COMPONENT POLYURETHANE PREPREGS AND SHAPED BODIES COMPOSED OF POLYURETHANE COMPOSITION THAT HAVE BEEN PRODUCED THEREFROM | EVONIK OPERATIONS GMBH (DE) | 2018-06-07 | — | — | US | claimed |
| US-20170145001-A1 | PROCESSES FOR PREPARING BREXPIPRAZOLE | SCINOPHARM TAIWAN, LTD. (TW) | 2017-05-25 | — | — | US | claimed |
| WO-2017078621-A1 | PROCESSES FOR PREPARING BREXPIPRAZOLE | SCINOPHARM TAIWAN, LTD. (TW) | 2017-05-11 | — | — | WO | claimed |
| US-20060216828-A1 | Rapid-response reversible dry surface CO2 detector | MERCURY ENTERPRISE, INC. | 2006-09-28 | — | — | US | claimed |
| EP-0511567-B1 | Polyorganosilazanes, process for their preparation and a process for making ceramic material | BAYER AG (DE) | 1995-09-20 | — | — | EP | claimed |
| EP-0511568-B1 | Polyorganosilazanes, process for their preparation and a process for making ceramic material | BAYER AG (DE) | 1995-08-02 | — | — | EP | claimed |
| US-5250648-A | Preparation of organic silizane polymers and ceramic materials therefrom | BAYER AKTIENGESELLSCHAFT (DE) | 1993-10-05 | — | — | US | claimed |
| US-5229338-A | Quaternary ammonium catalyst which is easily deactivated, silicon nitride | BAYER AKTIENGESELLSCHAFT (DE) | 1993-07-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200392067-A1 | TEREPHTHALIC ACID ESTERS FORMATION | ALKBH3, SLC16A1, TFEB | SLC22A1 1737/4885SLC22A2 1610/4885ALDH1A1 484/4885 |
| US-20190084916-A1 | TEREPHTHALIC ACID ESTERS FORMATION | ALKBH3, TERT, SLC16A1 | SLC22A1 1944/4885SLC22A2 1842/4885ALDH1A1 471/4885 |
| US-20210309601-A1 | TEREPHTHALIC ACID ESTERS FORMATION | ALKBH3, SLC16A1, TFEB | SLC22A1 1737/4885SLC22A2 1610/4885ALDH1A1 484/4885 |
| US-20170145001-A1 | PROCESSES FOR PREPARING BREXPIPRAZOLE | CYP2B6, CYP2C19, CYP3A4 | SLC22A1 4348/4885SLC22A2 3952/4885ALDH1A1 310/4885 |
| US-20260098348-A1 | ELECTROCHEMICAL CO-PRODUCTION OF HALOGEN AND HYDROGEN FROM WASTE PLASTIC | ADH1C, ADH1A, ADH5 | SLC22A1 2560/4885SLC22A2 2181/4885ALDH1A1 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.